Of note, IL-6-induced effects, which are deleterious in patients affected by psoriasis, could be instead protective in the cancer context and limit tumor growth and expansion, by promoting expansion of cytotoxic IL-17-producing T cells and preventing immune suppression by Treg. This evidence concerns the gene IL17A and cancer.